Lloyd Dutton July 14, 2019

Human Rabies Immunoglobulin (IM)

GlobalHuman Rabies Immunoglobulin (IM) Market Global Report gives in-depth analysis of existing state of the Human Rabies Immunoglobulin (IM) market as well as the competitive landscape, including wide-ranging key players, product scope, types, applications and essential Human Rabies Immunoglobulin (IM) market statistics for projecting growth worldwide during years 2019 – 2024.

About Human Rabies Immunoglobulin (IM):

Rabies immunoglobulin (RIG) is a medication made up of antibodies against the rabies virus. It is used to prevent rabies following exposure.Figure Human Rabies Immunoglobulin (IM) is rabies immunoglobulin antibody by the high price of healthy human plasma protein low temperature ethanol separation or other separation methods approved separation and purification, and by virus removal and inactivation treatment is made. Mainly used for rabies or other crazy animal bites, scratches patients passive immunization.

Request a Sample Copy of the Report at https://www.absolutereports.com/enquiry/request-sample/13841700     

Human Rabies Immunoglobulin (IM) Market Manufacturers (Sales Revenue, Price, Gross Margin, Main Products):

  • CSL Behring
  • Grifols
  • Sanofi
  • Sichuan Yuanda Shuyang
  • CNBG
  • Kamada
  • CBPO
  • Shuanglin Bio
  • Weiguang Bio
  • Shanghai RAAS
  • Bharat Serum
  • VINS
  • The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Human Rabies Immunoglobulin (IM) by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features

    Human Rabies Immunoglobulin (IM) Market Types:

  • ERIG
  • HRIG

    Human Rabies Immunoglobulin (IM) Market Applications:

  • Category II Exposure
  • Category III Exposure

    Inquire or share your questions if any before the purchasing this report: https://www.absolutereports.com/enquiry/pre-order-enquiry/13841700     

    The Human Rabies Immunoglobulin (IM) market report begins from overview of industry chain structure (2011-2019), and describes industry environment, then analyses market size and forecast of Human Rabies Immunoglobulin (IM) by product, region and application (2019-2024), in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.

    Scope of Report:

  • The classification according to the material of Human Rabies Immunoglobulin (IM) includes ERIG, HRIG, and the proportion of HRIG in 2017is about 86.7%, and the proportion is in increasing trend from 2013 to 2017.
  • For ERIGs, the dosage is 40 IU per kg body weight subject to a maximum of 3000 IU. For HRIGs, the dosage is 20 IU per kg body weight subject to a maximum of 1500 IU.
  • Human Rabies Immunoglobulin (IM) is widely used for the Category II Exposure and Category III Exposure, the most proportion of Human Rabies Immunoglobulin (IM) is used for Category III Exposure, and the proportion in 2017 is about 82.6%.
  • China is the largest sales place, with a sales market share nearly 61.4% in 2017, because of the population. North America enjoys 4.3% market share.
  • The worldwide market for Human Rabies Immunoglobulin (IM) is expected to grow at a CAGR of roughly 8.0% over the next five years, will reach 450 million US$ in 2024, from 290 million US$ in 2019, according to a new study.
  • This report focuses on the Human Rabies Immunoglobulin (IM) in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

    Highlights of the Report to estimate the market size of Human Rabies Immunoglobulin (IM) Competition:

    • Key Stakeholders
    • Human Rabies Immunoglobulin (IM) Manufacturers
    • International Trade Type Analysis
    • Human Rabies Immunoglobulin (IM) Distributors/Traders/Wholesalers
    • Human Rabies Immunoglobulin (IM) Subcomponent Manufacturers
    • Industry Association
    • Supply Chain Analysis
    • Downstream Vendors
    • Traders or Distributors with Contact Information by Region

    Geographically Human Rabies Immunoglobulin (IM) Market comprises of (Regional Output, Demand & Forecast by Countries): North America (United States, Canada, Mexico), South America (Brazil, Argentina, Ecuador, Chile), Asia Pacific (China, Japan, India, Korea), Europe (Germany, UK, France, Italy), Middle East Africa (Egypt, Turkey, Saudi Arabia, Iran) And More

    No.of Pages: 121

    Purchase this Report (Price 3480 USD for a Single-User License): https://www.absolutereports.com/purchase/13841700     

    Human Rabies Immunoglobulin (IM) Market Report helps to identify the overview of all products developed in granular detail, with comprehensive vision of latest innovations and milestones like companies currently operating in the market worldwide. With 5 years’ revenue forecast the report offers significant proposals for individuals and companies about new project investment opportunities of Human Rabies Immunoglobulin (IM) market before evaluating its feasibility.

    Contact Us:

    Name: Ajay More

    Phone: US +1424 253 0807/ UK +44 203 239 8187

    Email id- [email protected]

    Our Other Report: FRP Pipe Market 2019-2024 by Manufactures Types, Applications, Regions and Forecast to 2024